Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is the main dose-limiting side effect of neurotoxic chemotherapeutic agents. CIPN can lead not only to loss of physical function, difficulties in activities of daily living (ADLs), and decreased quality of life, but also to dose reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joo-Hee, Kim, Eun-Jung, Seo, Byung-Kwan, Lee, Sanghun, Lee, Seunghoon, Jung, So-Young, Lee, Min-Hee, Kim, Ae-Ran, Park, Hyo-Ju, Shin, Mi-Suk, Choi, Sun-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751258/
https://www.ncbi.nlm.nih.gov/pubmed/23945074
http://dx.doi.org/10.1186/1745-6215-14-254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751258/
https://www.ncbi.nlm.nih.gov/pubmed/23945074
http://dx.doi.org/10.1186/1745-6215-14-254

Ejemplares similares